Novagant, Inc. Appoints Vice President for New Product Development

Novagant, Inc. Appoints Vice President for New Product Development


    
      
      

LAGUNA HILLS, CA--(Marketwired - April 08, 2014) - Novagant, Inc. (PINKSHEETS: NVGT) is pleased to announce that the Company has appointed Michael Thornton as its Vice President with the primary role in product development based on his extensive experience based on:

• Michael being a 13th generation Herbalist with a focus and specialty in nutraceuticals and "food as medicine". 
• Michael being responsible for bringing countless innovations to the hemp medicine industry through other enterprises. 
• Michael being an inventor with active research and development projects in nutraceuticals and cultivation.

The Company welcomed Michael on board as it foresees significant progress with Michael's expertise and experience.

"We are pleased that Michael has agreed to join the Novagant family. He will add an invaluable component to the Company's upcoming expansion plans," said Chris Lolachi, Novagant's CEO.

For more information about the Company, please visit www.novagant.com.

About Novagant, Inc. Novagant, Inc. was incorporated in the state of Nevada on February 23, 1987 under the name of Kendrex Systems, Inc. The Company underwent several name changes, and ultimately on November 26, 2013 changed its name to Novagant, Inc.

Safe Harbor: Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact: Novagant, Inc. [e-mail]